EPISODE · Apr 7, 2026 · 21 MIN
EP032 | 史上最快核准！禮來口服減重新藥 Foundayo (Orforglipron) 完整介紹。
from 葉峻榳醫師學習護照 · host YehG.com
https://www.yehclinic.com/foundayo-orforglipron-oral-glp1-attain/減重這條路，許多人都走得充滿挫折與辛酸。但隨著醫學進步，現在有了更具突破性、更容易融入日常生活的全新體重管理藥物！就在 2026 年 4 月 1 日，美國 FDA 正式核准了禮來藥廠（Eli Lilly）研發的全新「口服 GLP-1 RA 減重藥物 Foundayo（學名：Orforglipron）」上市。這不僅是肥胖治療領域的一大福音，其「破紀錄的審查速度」與背後龐大的臨床實證，更是引發了醫學界與市場的熱烈討論。
Embed this episode
Ready to play
EP032 | 史上最快核准！禮來口服減重新藥 Foundayo (Orforglipron) 完整介紹。
0:00
21:00
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of 葉峻榳醫師學習護照?
This episode is 21 minutes long.
When was this 葉峻榳醫師學習護照 episode published?
This episode was published on April 7, 2026.
Can I download this 葉峻榳醫師學習護照 episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!